About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
N
Disease Modifying Anti-rheumatic Drugs and Lymphoma Risk in Rheumatoid Arthritis
By
Namrata Singh
2 Videos
445 views
November 21, 2022
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
22:08
RheumNow
RheumNow News Highlights: 11 Agents That Cause Arthritis, Lupus - Te…
Feat.
J. Cush
26:31
Cleveland Clinic Rheumatology
Clinical Approach to Diagnosis and Treatment of Cytokine Storm in Rh…
Feat.
R. Q. Cron
25:25
Keck School of Medicine of USC
Update on the New ANA Classification System
Feat.
E. Taylor-Albert
25:16
Cleveland Clinic Rheumatology
Integrative Health Approaches for Optimum Immune Health
Feat.
C. Wang
04:16
RheumNow
ACR Convergence 2023 Highlights: People with RA and Long COVID Had…
Feat.
R. Conway
26:16
EADV 2022 Conference Coverage
An Overview of Atypical Ulcers
Feat.
K. Isoherranen
19:36
EADV 2022 Conference Coverage
EADV 2022: Microbiota and Biofilms in Hidradenitis Suppurativa
Feat.
A. Nassif
06:20
Xavier Mariette
Malignancy Events in the Filgotinib Rheumatoid Arthritis and Ulcerat…
12:14
ACR Convergence 2021 Coverage
Occurrence of Basal Cell and Squamous Cell Carcinomas of the Skin Un…
Feat.
A. Strangfeld
23:17
Cedars Sinai
Medical Therapy Related Complications in IBD
Feat.
M. Long
08:19
RWCS
RWCS 2021 Highlights on Biologics/tsDMARDs: What Are the Commonly Co…
Feat.
A. Kavanaugh,
J. Cush
07:54
Hospital for Special Surgery
Serological Response to SARS-CoV-2 Vaccination in Patients Treated W…
Feat.
R. Spiera
10:25
Highlights from ACR Convergence 2023
ACR Convergence 2023 Highlights: Two-week Break in Methotrexate Trea…
Feat.
A. Abhishek
07:27
RheumNow
Steroids, COX-2 Inhibitors & Diagnosis of Musculoskeletal Compla…
Feat.
J. Cush
25:00
Cleveland Clinic Rheumatology
Challenges of Prevention and Treatment of COVID-19 in the Immunocomp…
Feat.
C. Calabrese
33:24
Cleveland Clinic Rheumatology
The Epidemic Long COVID-19: Questions & Implications for Rheumat…
Feat.
L. Calabrese
04:49
RheumNow
Rheumatoid Arthritis and Cancer: Does Treatment With Anti-Rheumatic …
Feat.
J. Kay
06:14
RheumNow
RA & DVT Management: Should RA/DVT Patients Stop JAK Inhibitors?…
Feat.
J. Cush
24:49
Cleveland Clinic Rheumatology
Current Status of COVID Vaccinology in the Compromised Host
Feat.
A. Kim
26:08
National Jewish Health
Time for a Paradigm Shift: Complex Interventions - Extending Pulmona…
Feat.
B. Make
